Skip to main content

2024 ISPE Annual Meeting

    Event Information
    Event Type

    The 2024 ISPE Annual Meeting will be held in Berlin, Germany, from August 24 to 28, 2024. More information on the conference can be found here.

    A variety of Sentinel-related work will be featured, including presentations, posters, and more. 


    • Advancing Drug Safety Signal Management through Multimodal Approaches in Networking
    • Methodological Advances in Regulatory Real World Evidence Generation Systems: Perspectives from Sentinel and DARWIN-EU
    • Natural Language Processing in Pharmacoepidemiology: Lessons from the Multi-source Observational Safety Study for Advanced Information Classification using NLP (MOSAIC-NLP)

    Oral Presentations

    • Assessment of Non-cardiac Congenital Malformations and In Utero Exposure to Modafinil/Armodafinil in the Sentinel Distributed Database
    • Comparative Bleeding Risks Among NOAC Users for Nonvalvular Atrial Fibrillation Aged <65 Years in the Sentinel System
    • Comparing the Risk of Adverse Infant Outcomes Among Pregnancies with and without COVID-19 in the Sentinel System
    • High-Dimensional Multiple Imputation (hdMI) Strategies for Partially Observed Confounders with Structured and Natural Language Processing-Derived Auxiliary Covariates
    • Predicting Causes of Death from Structured Electronic Health Records Using Machine Learning
    • Use of Hydrochlorothiazide in the United States Following Label Update About Skin Cancer Risk 


    • Analysis of Medicinal Product Utilization Data in the FDA Sentinel System to Inform the Development of a Pregnancy Safety Study Framework 
    • Analysis of New Molecular Entity Utilization Patterns using the Sentinel Distributed Database
    • Assessing Exposure to Recently Approved Medications to Inform Feasibility for Signal Identification Analyses in the FDA’s Sentinel System
    • Beta-Blocker-Associated Hypoglycemia in Pediatric Patients: Findings from the FDA Adverse Event Reporting System, National Poison Data System, Medical Literature, and Sentinel Distributed Database 
    • Characterization of COVID-19 Vaccine Data in the Sentinel System
    • Characterizing Infants in the Sentinel Distributed Database Mother-Infant Linkage Table 
    • Characterizing Inpatient Electronic Health Records (EHR) from a Large Hospital Network for Use in Neonatal Pharmacoepidemiology Studies in the United States 
    • Characterizing Pediatric Members in the Sentinel Distributed Database: An Update with Data from Medicaid
    • Comparative Postmarketing Safety Assessment of Baloxavir Marboxil vs Oseltamivir using TreeScan™
    • COVID-19 Related Changes in Healthcare Utilization Among Insured Persons in the US and its Impact on Pharmacoepidemiologic Research 
    • Patterns of Prescribing and Dispensing Medicines Among Non-Hospitalized Pregnant Women with COVID-19: A Prospective Meta-Analysis Pooling Findings from Healthcare Databases in Europe and North America
    • Pediatric Utilization of New Molecular Entities (NMEs): A Summary of Early Post-Marketing Uptake in the Sentinel Distributed Database
    • Prenatal and Congenital Syphilis in the US: Characterizing Screening and Treatment
    • Prevalence of Selected Health Conditions among Individuals with Childbearing Potential to Inform the Development of the Pregnancy Safety Study Framework 
    • Risk of Incident Inflammatory Bowel Disease in New Users of Dipeptidyl Peptidase 4 Inhibitors and Sodium Dependent Glucose Co-Transporter 2 Inhibitors in the FDA Sentinel System
    • Tree-Based Mining of Real-World Data for Potential Safety Signals Associated with the Use of Dupilumab in the United States (2017-2023) 
    • Untangling National Medicaid Data: 30 Data Quality Metrics to Support Maternal Health Studies in Two Common Data Models